Bifalgorithm post
So in summary according to this recent Panther meta-analysis as well as diving into the individual trials in some peripheral literature comparing P. Toy 12 inhibitor mono therapy with aspirin mono therapy for secondary prevention, it still questionable whether p. 12 inhibitors in properly conducted randomized blinded trials actually can't helpperform aspirin for secondary prevention. It seems that clopitorel could possibly do that, especially if your patients are not on otherwise could medical therapy with highpoency statins E, etc. And tyangullar monotherapy could possibly lead to more events like the ones that they found in Thapa. There is a possible advantage of using p. 2 12 inhibitors in favor of aspirin for any GI bleeding as aspirin is associated with direct mucosa injury along the GI tract, which is a known fact.
So in summary according to this recent Panther meta-analysis as well as diving into the individual trials in some peripheral literature comparing P. Toy 12 inh…
Ideas in this flowchart
- Comparison of P. 12 Inhibitors and Aspirin for Secondary Prevention
- Meta-Analysis Findings
- P. 12 Inhibitors vs. Aspirin
- Effectiveness in Secondary Prevention
- Clopidogrel Potential
- Patient Considerations
- GI Bleeding Advantage
- Aspirin's GI Tract Impact